HAEMATE P 500/1200 UI pdr et solv p sol inj

7680457800052 Pharmacode 7777835 CH-45780 B02BD06 06.01.1.
HAEMATE P 500/1200 UI pdr et solv p sol inj
HAEMATE P 500/1200 UI pdr et solv p sol inj
HAEMATE P 500/1200 UI pdr et solv p sol inj
1 / 3
google

Details

GTIN
7680457800052
Pharmacode
7777835
Product number
4578005
CPT
-
Packaging group
500
Unit
I.E.
Composition
Praeparatio cryodesiccata: factor VIII coagulationis humanus 500 U.I. et factor humanus von Willebrandi 1200 U.I., albuminum humanum, proteina plasmatis humani, glycinum, natrii chloridum, natrii citras anhydricus, pro praeparatione corresp. natrium 25.8 mg. Solvens: aqua ad iniectabile.

Articles (1)

Haemate P 500 IE/1200 IE Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Pulver
500
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
23/06/2026
Professional SmPC
Français
23/06/2026
Professional SmPC
Italien
23/06/2026

Detailed composition

Substance Quantity Type Category
factor VIII coagulationis humanus
500.0 UI Substance Wirkstoff (Principe actif)
aqua ad iniectabile
- Substance HNIDK
factor humanus von Willebrandi
1200.0 UI Substance Wirkstoff (Principe actif)
albuminum humanum
- Substance HNIDK
proteina plasmatis humani
- Substance HNIDK
glycinum
- Substance HNIDK
natrii chloridum
- Substance HNIDK
natrii citras anhydricus
- Substance HNIDK
natrium
25.8 MG Substance HBESI

Reimbursement information

Public price
CHF 510.05
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 15/03/1986

Authorization holder

CSL Behring AG

3014 Bern

Authorization information

Swissmedic authorization number
45780
Drug name
Haemate P, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Galenic form
PULP
ATC Code
B02BD06
Authorization status
Z
Dispensation category
B
First authorization
19/06/1984
Authorization expiration date
31/12/9999
IT number
06.01.1.
Domain
Human medicine
Field of application
Prophylaxe und Therapie von Blutungen bei Hämophilie A und beim von Willebrand Syndrom

Packaging details

Description (FR)
HAEMATE P 500/1200 UI pdr et solv p sol inj
Description (DE)
HAEMATE P 500/1200 I.E. Pulv und Lsm zur Inj Lsg
Market launch
15/02/2007
Narcotic (BTM)
No

Application methods

IV

Other packaging sizes

HAEMATE P 250/600 UI pdr et solv p sol inj
250 IE
View
HAEMATE P 1000/2400 UI pdr et solv p sol inj
1000 IE
View
Buy us a coffee Explore the data